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Abstract: Objectives: Renal damage is common in scleroderma. It can occur acutely or chronically. Renal reserve might 
already be impaired before it can be detected by laboratory findings. Microbubble-based contrast-enhanced ultrasound has 
been demonstrated to improve blood perfusion imaging in organs. Therefore, we conducted a study to assess renal 
perfusion in scleroderma patients utilizing this novel technique. 
Materials and Methodology: Microbubble-based contrast agent was infused and destroyed by using high mechanical 
index by Siemens Sequoia (curved array, 4.5 MHz). Replenishment was recorded for 8 seconds. Regions of interests 
(ROI) were analyzed in renal parenchyma, interlobular artery and renal pyramid with quantitative contrast software 
(CUSQ 1.4, Siemens Acuson, Mountain View, California). Time to maximal Enhancement (TmE), maximal enhancement 
(mE) and maximal enhancement relative to maximal enhancement of the interlobular artery (mE%A) were calculated for 
different ROIs. 
Results: There was a linear correlation between the time to maximal enhancement in the parenchyma and the glomerular 
filtration rate. However, the other parameters did not reveal significant differences between scleroderma patients and 
healthy controls. 
Conclusion: Renal perfusion of scleroderma patients including the glomerular filtration rate can be assessed using 
microbubble-based contrast media. 
Keywords: Scleroderma, renal perfusion, contrast-enhanced ultrasound. 
INTRODUCTION 
 Renal damage is common in connective tissue disease. In 
systemic sclerosis intimal edema and proliferation leads to 
narrowing and obliteration of small vessels. Acute renal 
failure (scleroderma renal crisis) or slow worsening of renal 
function can occur. Autopsy studies suggest that 60 to 80 per 
cent of patients with scleroderma have associated kidney 
disease [1, 2]. Renal reserve might already be impaired before 
clinical renal disease is detectable [3]. Furthermore, there is 
no laboratory or other method to predict scleroderma renal 
crisis. Improved imaging of renal perfusion using contrast-
enhanced ultrasound has been described previously [4]. We 
therefore conducted a pilot study to assess renal perfusion 
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by contrast-enhanced ultrasound in patients with scleroderma 
compared to healthy controls. 
MATERIALS AND METHODOLOGY 
 After approval by the local ethics committee, 
ultrasonographic examinations were conducted in 
scleroderma patients compared to healthy volunteers as age 
and sex matched control. Siemens Sequoia (curved array, 4.5 
MHz) was used for analysis, and kidneys were documented 
in B-Mode. The resistance index of the interlobular arteries 
was measured by color Doppler ultrasound. Measurement of 
the intrarenal resistance index has been widely established in 
the evaluation of renovascular changes and is a wide-spread 
method to get indirect information about the vessel 
resistance and the perfusion distal of the measuring point. 10 
millilitres (ml) of Sonovue ® contrast agent (Altana Pharma) 
were infused at 90 ml per hour. Sonovue is a suspension of 
phospholipid stabilized sulphur hexafluoride (SF6) 
microbubbles. 90% of microbubbles are smaller than 8.0 m,  
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(mean diameter 2.5 m) and have a strong echogenicity over 
the range of frequencies used in medical ultrasound 
examinations. Ultrasound was performed with the Sequoia 
CPS programme with a mechanical index of 0.21. After 
saturation of Sonovue in the kidneys a high mechanical 
index was used to destroy the contrast medium locally. 
Replenishment was recorded for 8 seconds. Regions of 
interests (ROI, Figs. 1-3) were analyzed in renal 
parenchyma, interlobular artery and renal pyramid with 
quantitative contrast software (CUSQ 1.4, Siemens Acuson, 
Mountain View, California) using a typical exponential 
function as estimation [5]. Slope, time to maximal 
Enhancement (TmE), maximal enhancement (mE) and 
maximal enhancement relative to maximal enhancement of 
the interlobular artery (mE%A) were calculated for different 
ROIs. Graphical and statistical analyses were performed by 
Pearson Correlation (two-sided confidence interval 95%) and 
Mann-Whitney test to compare between control and 
Scleroderma group using the software GraphPad Prism 3.02. 
Graphs are displayed with single patients’ results and 
median, minimum, maximum, and 25
th
 and 75
th
 percentile on 
the right side. Patients were characterized by autoantibody 
profile and concomitant medication. Modified Rodnan skin 
score was assessed. This score increases from 0 to 51 in 
severity and there is an association between severe skin 
involvement and burden of organ-based complications. 
 
Fig. (1). Regions of interest: Red – parenchyma, green – 
interlobular artery, blue – renal pyramid. 
RESULTS 
Patient Characteristics 
 Median (mean) age of healthy controls (n=12) was 49.5 
(50.6) years, Scleroderma patients (n=14) had a median age 
of 43.5 (42.4) years (p=0,1498; n.s.). Nine patients suffered 
from the diffuse form of systemic sclerosis, whereas 5 
patients presented with a limited form. Six patients were 
tested positive for antibodies against Scl70 (70 kD 
extractable immunoreactive fragment of anti-topoisomerase 
I), 2 patients against centromere protein B (CENP-B), and 1 
against ribonucleic acid (RNA) polymerase. Mean (median) 
disease duration was 6.1 (5.5) years. Eight patients had at 
least one digital ulcus at the time of examination. Seven 
patients had pulmonary manifestations, all patients had 
esophageal involvement. Three patients revealed a reduction 
in glomerular filtration rate below 80 ml/min. Five patients 
were treated with an angiotensin-converting-enzyme (ACE) 
inhibitor. In the group of healthy controls, no renal 
dysfunction became evident by labaratory testing and 
treatment with an ACE inhibitor was not reported. Inspite of 
this, there was no significant difference in glomerular 
filtration rate between both groups (estimated by using 
Modification of Diet in Renal Disease (MDRD) formula [6], 
validated only below 90ml/min, p=0,52). 
 
Fig. (2). Example of characterization of renal perfusion in different 
regions of interest. Destruction of microbubbles (**). Maximum 
enhancement (plateau) in renal parenchyma (red line, line of best fit 
yellow) is close to maximum enhancement in the interlobular artery 
(green line, line of best fit pink). Blue line (line of best fit blue): 
renal pyramids. 
 
Fig. (3). Pearson's Correlation between PTmE (time to maximal 
enhancement in renal parenchyma) and glomerular filtration rate 
(GFR) assessed by MDRD. 
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 Six patients were treated with corticosteroids of more 
than 5 mg of prednisone equivalent per day at the time of 
examination. All except one in the patient group were 
female. The mean (median, SD) modified rodnan skin score 
was determined at 10.8 (7.5, 9.0). 
Color Doppler Ultrasound 
 Resistance index was analyzed in the interlobular 
arteries. There were no significant differences between both 
groups (data not shown). 
Renal Perfusion Assessed by Microbubble-Based 
Contrast-Enhanced Ultrasound 
 Renal perfusion using Sonovue was recorded and 
afterwards quantified as described above. 
 Renal perfusion assessed by microbubble-based contrast-
enhanced ultrasound revealed a linear correlation between 
time to maximal enhancement in renal parenchyma (PTmE) 
and glomerular filtration rate (GFR) assessed by MDRD that 
was close to statistical significance. The correlation 
coefficient using Pearson’s linear correlation was determined 
at -0.52 (CI 0.95%, -0.8419 to 0.07911) with p=0.08 (Fig. 4). 
 
Fig. (4). Maximal enhancement in renal parenchyma relative to 
maximal enhancement interlobular arteries (mE%A). 
 However, there were no statistically significant 
differences regarding time to maximal enhancement in renal 
parenchyma (PTmE, data not shown) or artery (ATmE, data 
not shown), maximal enhancement in renal parenchyma 
(PmE, data not shown), maximal enhancement in 
parenchyma relative to maximal enhancement of the 
interlobular artery (mE%A, Fig. 4), and slope in renal 
parenchyma (first ascending part of the curve resembling the 
speed of blood moving into the selected region (Fig. 5). 
DISCUSSION 
 Estimation of renal perfusion by microbubble-based 
contrast media was established in a phantom [5]. Contrast-
enhancend ultrasound has been demonstrated to detect 
perfusion differences in transplanted kidneys that were about 
to be rejected compared to non-rejected kidneys [7], and to 
determine other causes of delayed graft function [8]. 
Applying this novel technique to scleroderma patients to 
assess renal function, we were able to reveal a correlation 
between GFR and the time until maximal enhancement of 
 
 
Fig. (5). Quantification of renal perfusion by slope in renal 
parenchyma (slope). 
microbubbles in the renal parenchyma (PTmE). However, 
some limitations need to be considered when evaluating this 
finding. The correlation was only close to statistical 
significance and a larger cohort of scleroderma patients is 
required to further analyze the correlation and find out 
whether this novel method might provide substantial 
information beyond the glomerular filtration rate. There was 
no dose finding study ahead and the level of microbubble 
saturation might have influence on test results. There is a 
limitation of this calculation as the GFR estimated by 
MDRD was mainly established in a patient cohort presenting 
with a GFR below 90 ml/min. In a very small previously 
published scleroderma group, there were significant 
differences observed in maximal enhancement in 
parenchyma relative to maximal enhancement in interlobular 
arteries (Pmax%A) compared to normal controls [9]. This 
parameter suggests a higher independence of renal perfusion 
since this parameter is calculated as an intra-individual 
relation of perfusion that might be independent from the 
filling of the extrarenal vessels. However, in our study, we 
were not able to confirm these differences in Pmax%A (Fig. 
4). We could neither demonstrate differences in time until 
maximal enhancement in the parenchyma (PTmE) nor in the 
interlobular arteries (ATmE) compared to healthy controls. 
Neither maximal enhancement in the renal parenchyma 
(PmE) nor the height of the slope in parenchyma (slope, Fig. 
5) revealed significant differences compared to healthy 
controls. Therefore, no additional parameter could be 
identified to assess subclinical renal changes. Nevertheless, 
our pilot study suggests the feasibility to assess renal 
perfusion including the glomerular filtration rate of 
scleroderma patients by microbubble-based contrast media. 
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